Structures by: Zhang X. R.
Total: 21
C27H32N2O4
C27H32N2O4
Journal of medicinal chemistry (2018) 61, 22 9908-9930
a=9.41991(12)Å b=10.11440(12)Å c=23.7285(4)Å
α=90° β=91.6653(13)° γ=90°
C42H27N3O6
C42H27N3O6
Organic letters (2006) 8, 12 2563-2566
a=9.4420(19)Å b=14.643(3)Å c=23.704(5)Å
α=90.00° β=93.98(3)° γ=90.00°
C42H27N3O6
C42H27N3O6
Organic letters (2006) 8, 12 2563-2566
a=11.504(2)Å b=15.323(3)Å c=18.698(4)Å
α=90.00° β=98.95(3)° γ=90.00°
C20H17Cl2N5O11
C20H17Cl2N5O11
CrystEngComm (2015) 17, 33 6338
a=8.9344(2)Å b=18.8814(6)Å c=14.1420(4)Å
α=90° β=90.449(2)° γ=90°
C20H17Cl2N5O11
C20H17Cl2N5O11
CrystEngComm (2015) 17, 33 6338
a=9.7180(5)Å b=10.2978(5)Å c=12.2586(5)Å
α=89.871(4)° β=80.340(4)° γ=74.104(4)°
C20H17Cl2N5O11
C20H17Cl2N5O11
CrystEngComm (2015) 17, 33 6338
a=32.842(7)Å b=8.4292(17)Å c=17.392(4)Å
α=90° β=103.11(3)° γ=90°
C11H13N5O7P2Zn2
C11H13N5O7P2Zn2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 35 12468-12473
a=10.5638(9)Å b=20.5737(13)Å c=8.2585(7)Å
α=90° β=104.442(9)° γ=90°
C11H14N5O10P3Zn3
C11H14N5O10P3Zn3
Dalton transactions (Cambridge, England : 2003) (2018) 47, 35 12468-12473
a=15.8155(11)Å b=8.3224(7)Å c=17.1936(12)Å
α=90° β=90° γ=90°
(1,4,7,10-Tetraazacyclododecane-κ^4^<i>N</i>)bis(tricyanomethanido-κ<i>N</i>)nickel
C16H20N10Ni
Acta Crystallographica Section E (2015) 71, 6 693-697
a=10.6300(12)Å b=11.0150(12)Å c=17.1771(18)Å
α=90° β=104.828(2)° γ=90°
(1,4,7,10-Tetraazacyclododecane-κ^4^<i>N</i>)(tricyanomethanido-κ<i>N</i>)copper tricyanomethanide
C16H20CuN10
Acta Crystallographica Section E (2015) 71, 6 693-697
a=7.4074(15)Å b=11.552(2)Å c=11.625(2)Å
α=89.187(3)° β=88.236(3)° γ=78.579(3)°
2-(4-Phenyl-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-(<i>p</i>-tolyl)acetamide
C17H16N4O
Acta Crystallographica Section E (2008) 64, 8 o1612
a=5.5923(7)Å b=30.438(4)Å c=9.6112(10)Å
α=90.00° β=115.595(6)° γ=90.00°
<i>catena</i>-Poly[[(2,2:6',2''- terpyridine-κ^3^<i>N</i>,<i>N</i>',<i>N</i>'')(tricyanomethanido- κ<i>N</i>)nickel(II)]-μ-tricyanomethanido]
C46H22N18Ni2
Acta Crystallographica Section E (2008) 64, 10 m1322-m1323
a=8.410(3)Å b=15.581(5)Å c=16.816(5)Å
α=93.762(4)° β=90.110(4)° γ=97.572(5)°
3-Benzylsulfanyl-5-(4-phenyl-1<i>H</i>-1,2,3-triazol-1-ylmethyl)-4<i>H</i>- 1,2,4-triazol-4-amine
C18H17N7S
Acta Crystallographica Section E (2008) 64, 8 o1611
a=8.0487(15)Å b=5.4689(10)Å c=38.721(7)Å
α=90.00° β=90.00° γ=90.00°
Bis(2,2-bipyridyl dioxide-κ^2^<i>N</i>,<i>N</i>')bis(tricyanomethanido)cobalt(II) dihydrate
C28H16CoN10O4,2(H2O)
Acta Crystallographica Section E (2010) 66, 6 m673-m674
a=9.575(3)Å b=16.699(6)Å c=9.442(3)Å
α=90.00° β=95.307(4)° γ=90.00°
Bis(2,2':6',2''-terpyridine)cobalt(II) bis(tricyanomethanide)
C30H22CoN62,2(C4N3)
Acta Crystallographica Section E (2009) 65, 4 m455-m456
a=9.042(3)Å b=9.167(3)Å c=40.340(14)Å
α=90.00° β=91.163(6)° γ=90.00°
(<i>R</i>~C~,<i>S</i>~Fe~)-1-[3,5-Bis(trifluoromethyl)phenyl]-3-{1-[2-(diphenylphosphanyl)ferrocenyl]ethyl}thiourea (unknown solvate)
C33H27F6FeN2PS
Acta Crystallographica Section E (2013) 69, 5 m242-m243
a=20.0898(16)Å b=20.0898(16)Å c=18.012(2)Å
α=90.00° β=90.00° γ=90.00°
Bis(dicyanamido-κ<i>N</i>)[tris(3-aminopropyl)amine-κ^4^<i>N</i>]nickel(II)
C13H24N10Ni
Acta Crystallographica Section E (2013) 69, 7 m385-m386
a=10.1710(10)Å b=11.3960(11)Å c=15.5305(15)Å
α=90.00° β=105.660(2)° γ=90.00°
C23H39Cl2GaN2O
C23H39Cl2GaN2O
Inorganic chemistry (2017) 56, 3 1375-1385
a=10.4391(10)Å b=17.9407(16)Å c=12.9885(12)Å
α=90° β=92.392(2)° γ=90°
C27H42ClGaN2O2
C27H42ClGaN2O2
Inorganic chemistry (2017) 56, 3 1375-1385
a=13.7473(7)Å b=16.7022(8)Å c=12.3646(6)Å
α=90° β=106.037(3)° γ=90°
C20H35Cl2GaN2O
C20H35Cl2GaN2O
Inorganic chemistry (2017) 56, 3 1375-1385
a=25.2656(14)Å b=8.7602(5)Å c=22.4718(11)Å
α=90° β=116.298(3)° γ=90°
C38H57GaN2O3,C4H10O
C38H57GaN2O3,C4H10O
Inorganic chemistry (2017) 56, 3 1375-1385
a=13.2214(6)Å b=13.1233(6)Å c=23.7269(11)Å
α=90° β=92.663(2)° γ=90°